🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Vaccines made from tumor antigens may help the body build an eff...
Status
Withdrawn
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00693342
Treatments Being Tested
Sarcoma patients are at high risk for their cancer to recur even when the s...
Status
Completed
Location
UCLA Medical Center
Start Date
2010-06
Trial ID
NCT01141491
Treatments Being Tested
This randomized phase II trial studies OPT-821 and vaccine therapy to see h...
Status
Completed
Location
University of South Alabama Mitchell Cancer Institute
Start Date
2010-07
Trial ID
NCT00857545
The purpose of the study is to explore the combination of a bivalent vaccin...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2021-08-02
Trial ID
NCT04936529
Vaccines contain substances that help us make antibodies. Different antibod...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2007-12
Trial ID
NCT00597272
Treatments Being Tested
The purpose of this study is to test which treatment schedule of β-glucan w...
Status
Recruiting
Location
Memorial Sloan Kettering at Basking Ridge (Consent only)
Start Date
2023-09-21
Trial ID
NCT06057948
Treatments Being Tested
In the first part of this study we found the highest dose of the vaccine th...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2009-05-27
Trial ID
NCT00911560
The purpose of this study is to evaluate the effect of OPT-822/OPT-821 on i...
Status
Unknown
Location
Mackay Memorial Hospital
Start Date
2013-11
Trial ID
NCT02132988
Treatments Being Tested
The immune system of the body has the ability to fight and eliminate infect...
Status
Completed
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2010-10
Trial ID
NCT01223235
Treatments Being Tested
The purpose of this study is to compare active immunotherapy (OPT-822/OPT-8...
Status
Completed
Location
The University of Alabama at Birmingham (UAB)
Start Date
2011-12
Trial ID
NCT01516307
Treatments Being Tested